According to our (Global Info Research) latest study, the global Streptavidin Resin market size was valued at US$ 45.27 million in 2025 and is forecast to a readjusted size of US$ 80.99 million by 2032 with a CAGR of 8.6% during review period.
Streptavidin resin is an affinity chromatography medium in which streptavidin is covalently immobilized on solid supports such as agarose, Sepharose, or magnetic beads. It is used to capture, immobilize, or purify biotin-labeled proteins, antibodies, nucleic acids, and probes. The product’s gross margin is approximately 62%.
Streptavidin resin represents a small but high-value affinity purification consumable. Demand is primarily driven by protein–protein interaction studies, antibody–antigen capture, nucleic acid probe enrichment, and preparation of biotinylated samples. It is not a mainstream Protein A resin for large-scale antibody production; the market size is relatively small, but unit prices are high, SKUs are diverse, and customers prioritize binding capacity, low nonspecific adsorption, leaching control, and batch consistency.
Growth is fueled by two main scenarios: (1) stable consumption in research for proteomics, pull-downs, immunoprecipitation, and nucleic acid capture; (2) process development applications, where the biotin–streptavidin system serves as a general immobilization platform for small-scale purification, ligand screening, and automated sample preparation. Magnetic beads and pre-packed columns divert some demand from traditional bulk resin but also increase average customer spend.
The competitive landscape is led by international brands such as Thermo Fisher, Cytiva, and Merck, which dominate high-end research and methodology validation use cases. Chinese suppliers fill the market for 6FF agarose resin, gravity columns, and standard formats with lower prices and more flexible delivery. The market is expected to maintain mid-to-high single-digit growth, driven by life sciences R&D investment, automated sample preparation, and domestic substitution.
This report is a detailed and comprehensive analysis for global Streptavidin Resin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Streptavidin Resin market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Streptavidin Resin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Streptavidin Resin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Streptavidin Resin market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Streptavidin Resin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Streptavidin Resin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Cytiva, Merck, GenScript, Vector Laboratories, Abcam, GoldBio, G-Biosciences, UBPBio, Yeasen Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Streptavidin Resin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bulk Slurry
Prepacked Column
Spin Column
Multiwell Plate
Magnetic Beads
Other Form
Market segment by Matrix Performance
Standard Agarose
High-Flow Agarose
High-Resolution Agarose
Magnetic Matrix
Other Matrix
Market segment by Binding Capacity
Standard Capacity
High Capacity
Ultra Capacity
Custom Capacity
Other Capacity
Market segment by Application
Biotinylated Protein Purification
Antibody-Antigen Capture
Pull-Down Assay
Immunoprecipitation
Nucleic Acid Capture
Probe Immobilization
Assay Development
Major players covered
Thermo Fisher Scientific
Cytiva
Merck
GenScript
Vector Laboratories
Abcam
GoldBio
G-Biosciences
UBPBio
Yeasen Biotechnology
Smart Lifesciences
Beyotime Biotechnology
MedChemExpress
TargetMol
Marvelgent
Protein Ark
Biorigin
ChomixBio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Streptavidin Resin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Streptavidin Resin, with price, sales quantity, revenue, and global market share of Streptavidin Resin from 2021 to 2026.
Chapter 3, the Streptavidin Resin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Streptavidin Resin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Streptavidin Resin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Streptavidin Resin.
Chapter 14 and 15, to describe Streptavidin Resin sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Streptavidin Resin. Industry analysis & Market Report on Streptavidin Resin is a syndicated market report, published as Global Streptavidin Resin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Streptavidin Resin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.